Consortium of Probiotics Attenuates Colonization of Clostridioides difficile.
Ontology highlight
ABSTRACT: Clostridioides difficile infection (CDI) is increasing morbidity and mortality rates globally. Fecal microbiota transplantation (FMT), an effective therapy for eliminating Clostridioides difficile (C. difficile), cannot be used extensive due to a range of challenges. Probiotics thus constitutes a promising alternative therapy. In our study, we evaluated the effect of consortium of probiotics including five Lactobacilli strains and two Bifidobacterium strains on the colonization of toxigenic BI/NAP1/027 C. difficile in a mouse model. The results of 16S rRNA sequencing and targeted metabolomics showed the consortium of probiotics effectively decreased the colonization of C. difficile, changed the α- and β-diversity of the gut microbiota, decre
SUBMITTER: Li X
PROVIDER: S-EPMC6920126 | biostudies-literature | 2019
REPOSITORIES: biostudies-literature
ACCESS DATA